Race adjustment

Last updated

Race adjustment, also known as race-correction, [1] [2] is the calculating of a result which takes into account race. [1] It is commonly used in medical algorithms in several specialties, including cardiology, nephrology, urology, obstetrics, endocrinology, oncology and respiratory medicine. [1] Examples include the eGFR to assess kidney function, [1] the STONE score for the prediction of kidney stones, [1] [3] the FRAX tool, to evaluate the 10-year probability of bone fracture risk, [1] [4] and lung function tests, to identify the severity of lung disease. [1] [5]

Contents

Types and medical uses

Adjustments for race are commonly used in several medical specialties, including cardiology, nephrology, urology, obstetrics, endocrinology, oncology and respiratory medicine. [1] Examples include the eGFR to assess kidney function, [1] the STONE score for the prediction of kidney stones, [1] [3] the FRAX tool, to evaluate the 10-year probability of bone fracture risk, [1] [4] and lung function tests, to identify the severity of lung disease. [1] [5]

Nephrology

The estimated glomerular filtration rate (eGFR) is a measure of kidney function. [6] Adding a race adjustment to kidney algorithms results in higher eGFR values in people identified as black. [7] [8] [9] Reasons for this vary, but it is thought to partially stem from the notion that Black persons are more muscular. [8] This idea has come under greater scrutiny, with certain institutions choosing to deviate from the race-adjusted model as a result. [10]

Kidney transplants also have racial implications, both direct and indirect. The Kidney Donor Risk Index (KDRI), the United States' official kidney allocation index, was developed in 2014. [11] Race is among the factors used to predict the success of a kidney graft, with Black donors' kidneys often thought to perform worse than kidneys from other donors. [12] Being Black results in a demarcation as a less preferable donor by the KDRI. [13] This creates a snowball effect, with less kidneys from Black donors in the system. In turn, Black people in need of kidney donations are affected. Black people already face longer wait times than people of other races in need of kidney transplants. Black people are more likely to receive a kidney transplant from a Black donor, according to recent studies. [13] This lack of resources can exacerbate the already lengthy wait times. In recent years, some professionals have called attention to these disparities, advocating to replace "the vagaries associated with inclusion of a variable termed 'race'." [12]

Obstetrics

In the United States, African American and Hispanic women continue to have higher rates of cesarean section than do white women in the US. [14] Medical decision making formulas such as the Vaginal Birth after Cesarean (VBAC) algorithm have been found to contribute to such disparities for women of color. The VBAC is used to estimate success rates for vaginal birth among expectant mothers with histories of previous cesarean delivery and is used by clinicians to counsel whether to offer trials of labor or repeat cesarean section. [15] There are two race-based correction factors incorporated in the formula, one for African American women and one for Hispanic women. These factors are subtracted from the likelihood of having a successful vaginal birth after Cesarean and thus inherently predict a lower risk of vaginal birth success for African American and Hispanic individuals. [16] These lower estimates may discourage health providers from offering trials of vaginal labor to expectant women of color, although the health benefits of vaginal birth (lower rates of surgical complication, faster recovery, fewer complication in later pregnancies) have been well documented. [17] These race/ethnicity associations have been challenged by health providers since they have not been thoroughly supported by biology and are concerning as black women have higher rates of maternal mortality. [18]

Pulmonology

Spirometers are devices that measure lung volume and airflow. They are used for the diagnosis and monitoring of several respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). [19] In the United States, spirometers use "correction factors" for individuals labelled as Black (10-15%) or Asian (4-6%). [17] There have been several concerns about equity in these lung function formulas including the misdiagnosis of disease severity in asthma and COPD. [20] Recent interest in investigating the basis for why these correction factors came to be spawned a systematic review of 226 articles published between 1922 and 2008 that found that less than one in five studies defined race and that researchers frequently assumed inherent or genetic differences. [21] Supporters of using race adjustment in lung function argue that despite its imperfections, correcting for race results in a more precise calculation of lung function and that not including the adjustment may result in misdiagnosis. [22]

History

Racially-biased discourse was pervasive in the development of Western medical thought. Carl Linnaeus, a Swedish physician, labeled five varieties of the human species by their physiognomic characteristics. [23] He included characteristics such as hair type and skin thickness, but also relative characteristics relating to greed, honor, and laziness. [23]

Charles White. an English physician and surgeon, further believed that different races were aligned on a "Great Chain of Being". [24] His beliefs espoused different origins for different races, claiming that white and black people were different species entirely. [24] While others, such as French naturalist Georges-Louis Leclerc and German anatomist Johann Blumenbach believed all races came from a single origin point, but that the races degenerated over time to form distinct differences based on environmental factors. [25] Others like Thomas Jefferson believed that there was obvious racial inferiority between white and Black persons, calling on science to explore it further. [26] While Charles Darwin believed in the basic equality of the human species, his ideas were adapted by social theorists like Francis Galton who coined the term eugenics in his book Inquiries into Human Faculty and Its Development published in 1883. [27]

Influence of slavery and eugenics on medical practices

Perceived differences in race were used to justify slavery in the United States and these beliefs impacted medical treatment and experimentation on Black persons in the United States. [28] Medical treatment of Black persons in the United States came into specific focus after 1808, after a federal ban on slave imports was implemented. [29] Physicians such as J Marion Sims started to focus on the existing Black population, attempting to observe and use Black slaves for medical reasons. [30] [29] Some of these treatments and experiments were for the broader medical community, others were to increase birth rates and therefore domestic slave populations. Sims, for instance, the father of modern gynecology, performed surgery on twelve women in the 1840s from his backyard in Montgomery, Alabama. [31] All of the women were enslaved. [31] As modern medical science grew, it developed in conjunction with notions of racism, derived from both experiments and societal sentiments. These factors embedded a sense of racial difference and inequity that persists today. In the modern United States, for instance, Black women are sometimes three to four times more likely to die from issues during pregnancy compared to white women. [29]

Experimentation was widespread among medical students and professionals alike. In the 19th century, many American medical schools used Black bodies stolen through grave robbing for dissection and medical experimentation. [32] This thought process of viewing Black bodies and persons, alive or dead, as an "other", ripe for experimentation, persisted well into the Jim Crow era. For instance, the Tuskegee Experiment, initiated in 1932 and ending in 1972, infected Black men with syphilis against their knowledge, leading to over 100 deaths. [33]

This experimentation went hand in hand with a legacy of colonialism. Colonies served as ample testing grounds for medical advancements by European and North American medical professionals. [34] [35] Honor Smith, a British physician at Oxford University, was jovial about the opportunity to test on colonial populations; in 1955, he stated, "[I]t is the almost unlimited field that Africa offers for clinical research that I find so enthralling…problems of the first interest abound, [and] clinical material is unlimited." [36]

These experiments coincided with developments in anthropology and theory around race, with many prevalent thinkers of the time believing there to be distinct differences, even distinct origins between different races. [26] After World War II, scientific racism and eugenics began to be dismissed at large by the scientific community. While certain experiments and explicitly eugenicist thought continued, many of the theories surrounding racial difference and eugenic superiority were discredited and pushed out of the mainstream. [37] Certain medical practices such as equations and decision-making tools continued with these biases in mind. As the internet developed, diagnostic tools were often based on decision-making tools embedded with a perceived racial difference. [38] In the 21st century, these tools and methods have come under more scrutiny. [38]

Society, culture and research

As understanding of race and ethnicity has evolved, advocates for change, such as Lundy Braun, have questioned the assumptions that some medical decision-making tools and formulas are based upon. [1] [5] These formulas have been documented [1] to result in the denial of certain resources and treatment options to people identified as black. [39] However, Neil R. Powe, professor of medicine and researcher in health disparities and co-author on a study of the implications of omitting the race adjustment in eGFR calculations, highlights the risks in leaving it out. [40]

In recent years, students, petitions and social media campaigns have recently been at the forefront for driving medical institutions to change the way they utilize certain clinical decision-making tools such as eGFR calculations. [41] In 2017, Beth Israel Medical Centre eliminated the race factor in calculating kidney function. [38] In May 2020, through medical student advocacy to their administration, the University of Washington transitioned to a new eGFR calculation that excludes race as a variable. [42]

See also

Related Research Articles

<span class="mw-page-title-main">Kidney</span> Organ that filters blood and produces urine

In humans, the kidneys are two reddish-brown bean-shaped blood-filtering organs that are a multilobar, multipapillary form of mammalian kidneys, usually without signs of external lobulation. They are located on the left and right in the retroperitoneal space, and in adult humans are about 12 centimetres in length. They receive blood from the paired renal arteries; blood exits into the paired renal veins. Each kidney is attached to a ureter, a tube that carries excreted urine to the bladder.

<span class="mw-page-title-main">Caesarean section</span> Surgical procedure in which a baby is delivered through an incision in the mothers abdomen

Caesarean section, also known as C-section or caesarean delivery, is the surgical procedure by which one or more babies are delivered through an incision in the mother's abdomen, often performed because vaginal delivery would put the baby or mother at risk. Reasons for the operation include obstructed labor, twin pregnancy, high blood pressure in the mother, breech birth, shoulder presentation, and problems with the placenta or umbilical cord. A caesarean delivery may be performed based upon the shape of the mother's pelvis or history of a previous C-section. A trial of vaginal birth after C-section may be possible. The World Health Organization recommends that caesarean section be performed only when medically necessary.

<span class="mw-page-title-main">Childbirth</span> Expulsion of a fetus from the pregnant mothers uterus

Childbirth, also known as labour, parturition and delivery, is the completion of pregnancy where one or more babies exits the internal environment of the mother via vaginal delivery or caesarean section. In 2019, there were about 140.11 million human births globally. In the developed countries, most deliveries occur in hospitals, while in the developing countries most are home births.

<span class="mw-page-title-main">Organ transplantation</span> Medical procedure in which an organ is removed from one body and placed in the body of a recipient

Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or tissues that are transplanted within the same person's body are called autografts. Transplants that are recently performed between two subjects of the same species are called allografts. Allografts can either be from a living or cadaveric source.

<span class="mw-page-title-main">Kidney failure</span> Disease where the kidneys fail to adequately filter waste products from the blood

Kidney failure, also known as end-stage kidney disease, is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels. Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible. Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion. Complications of acute and chronic failure include uremia, hyperkalaemia, and volume overload. Complications of chronic failure also include heart disease, high blood pressure, and anaemia.

<span class="mw-page-title-main">Glomerular filtration rate</span> Renal function test

Renal functions include maintaining an acid–base balance; regulating fluid balance; regulating sodium, potassium, and other electrolytes; clearing toxins; absorption of glucose, amino acids, and other small molecules; regulation of blood pressure; production of various hormones, such as erythropoietin; and activation of vitamin D.

<span class="mw-page-title-main">Kidney disease</span> Damage to or disease of a kidney

Kidney disease, or renal disease, technically referred to as nephropathy, is damage to or disease of a kidney. Nephritis is an inflammatory kidney disease and has several types according to the location of the inflammation. Inflammation can be diagnosed by blood tests. Nephrosis is non-inflammatory kidney disease. Nephritis and nephrosis can give rise to nephritic syndrome and nephrotic syndrome respectively. Kidney disease usually causes a loss of kidney function to some degree and can result in kidney failure, the complete loss of kidney function. Kidney failure is known as the end-stage of kidney disease, where dialysis or a kidney transplant is the only treatment option.

<span class="mw-page-title-main">Amniotic fluid</span> Fluid surrounding a fetus within the amnion

The amniotic fluid is the protective liquid contained by the amniotic sac of a gravid amniote. This fluid serves as a cushion for the growing fetus, but also serves to facilitate the exchange of nutrients, water, and biochemical products between mother and fetus.

<span class="mw-page-title-main">Kidney transplantation</span> Medical procedure

Kidney transplant or renal transplant is the organ transplant of a kidney into a patient with end-stage kidney disease (ESRD). Kidney transplant is typically classified as deceased-donor or living-donor transplantation depending on the source of the donor organ. Living-donor kidney transplants are further characterized as genetically related (living-related) or non-related (living-unrelated) transplants, depending on whether a biological relationship exists between the donor and recipient.

Pelvimetry is the measurement of the female pelvis. It can theoretically identify cephalo-pelvic disproportion, which is when the capacity of the pelvis is inadequate to allow the fetus to negotiate the birth canal. However, clinical evidence indicate that all pregnant women should be allowed a trial of labor regardless of pelvimetry results.

Prostaglandin E<sub>2</sub> Chemical compound

Prostaglandin E2 (PGE2), also known as dinoprostone, is a naturally occurring prostaglandin with oxytocic properties that is used as a medication. Dinoprostone is used in labor induction, bleeding after delivery, termination of pregnancy, and in newborn babies to keep the ductus arteriosus open. In babies it is used in those with congenital heart defects until surgery can be carried out. It is also used to manage gestational trophoblastic disease. It may be used within the vagina or by injection into a vein.

Caesarean delivery on maternal request (CDMR) is a caesarean section birth requested by the pregnant woman without a medical reason.

In case of a previous caesarean section a subsequent pregnancy can be planned beforehand to be delivered by either of the following two main methods:

<span class="mw-page-title-main">Carbetocin</span> Pabal contains carbetocin used for preventing postpartum bleeding. Potent than oxytocin.

Carbetocin, sold under the brand names Pabal among others, is a medication used to prevent excessive bleeding after childbirth, particularly following Cesarean section. It appears to work as well as oxytocin. Due to it being less economical than other options, use is not recommended by NHS Scotland. It is given by injection into a vein or muscle.

<span class="mw-page-title-main">Vaginal delivery</span> Delivery through the vagina

A vaginal delivery is the birth of offspring in mammals through the vagina. It is the most common method of childbirth worldwide. It is considered the preferred method of delivery, with lower morbidity and mortality than Caesarean sections (C-sections).

<span class="mw-page-title-main">Heart transplantation</span> Surgical transplant procedure

A heart transplant, or a cardiac transplant, is a surgical transplant procedure performed on patients with end-stage heart failure or severe coronary artery disease when other medical or surgical treatments have failed. As of 2018, the most common procedure is to take a functioning heart, with or without both lungs, from a recently deceased organ donor and implant it into the patient. The patient's own heart is either removed and replaced with the donor heart or, much less commonly, the recipient's diseased heart is left in place to support the donor heart.

Vaginal transplantation is procedure whereby donated or laboratory-grown vagina tissue is used to create a 'neovagina'. It is most often used in women who have vaginal aplasia.

Neil R. Powe is an American professor of medicine at the University of California, San Francisco and the chief of medicine at the Zuckerberg San Francisco General Hospital and Trauma Center. Previously he was professor of medicine at the Johns Hopkins University School of Medicine. His research has mainly related to kidney disease, cardiovascular disease and health disparities.

<span class="mw-page-title-main">Andrew S. Levey</span> American nephrologist (born 1950)

Andrew S. Levey is an American nephrologist who transformed chronic kidney disease (CKD) clinical practice, research, and public health by developing equations to estimate glomerular filtration rate (GFR), and leading the global standardization of CKD definition and staging.

Maternal health outcomes differ significantly between racial groups within the United States. The American College of Obstetricians and Gynecologists describes these disparities in obstetric outcomes as "prevalent and persistent." Black, indigenous, and people of color are disproportionately affected by many of the maternal health outcomes listed as national objectives in the U.S. Department of Health and Human Services's national health objectives program, Healthy People 2030. The American Public Health Association considers maternal mortality to be a human rights issue, also noting the disparate rates of Black maternal death. Race affects maternal health throughout the pregnancy continuum, beginning prior to conception and continuing through pregnancy (antepartum), during labor and childbirth (intrapartum), and after birth (postpartum).

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Vyas, Darshali A.; Eisenstein, Leo G.; Jones, David S. (27 August 2020). "Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms". New England Journal of Medicine. 383 (9): 874–882. doi: 10.1056/NEJMms2004740 . ISSN   0028-4793. PMID   32853499.
  2. Costanza-Chock, Sasha (2020). Design Justice: Community-Led Practices to Build the Worlds We Need. MIT Press. p. 41. ISBN   978-0-262-04345-8.
  3. 1 2 Wang, Ralph C.; Rodriguez, Robert M.; Moghadassi, Michelle; Noble, Vicki; Bailitz, John; Mallin, Mike; Corbo, Jill; Kang, Tarina L.; Chu, Phillip; Shiboski, Steve; Smith-Bindman, Rebecca (April 2016). "External Validation of the STONE Score, a Clinical Prediction Rule for Ureteral Stone: An Observational Multi-institutional Study". Annals of Emergency Medicine. 67 (4): 423–432.e2. doi:10.1016/j.annemergmed.2015.08.019. ISSN   0196-0644. PMC   4808407 . PMID   26440490.
  4. 1 2 Almoallim, Hani (2016). Skills in Rheumatology. Elsevier Health Sciences. p. 224. ISBN   978-0-7020-7454-7.
  5. 1 2 3 Braun, Lundy (2015). "Race, ethnicity and lung function: A brief history". Canadian Journal of Respiratory Therapy. 51 (4): 99–101. ISSN   1205-9838. PMC   4631137 . PMID   26566381.
  6. "eGFR calculator". pathlabs.rlbuht.nhs.uk. Retrieved 19 April 2021.
  7. Levey, Andrew S.; Stevens, Lesley A.; Schmid, Christopher H.; Zhang, Yaping (Lucy); Castro, Alejandro F.; Feldman, Harold I.; Kusek, John W.; Eggers, Paul; Van Lente, Frederick; Greene, Tom; Coresh, Josef (5 May 2009). "A New Equation to Estimate Glomerular Filtration Rate". Annals of Internal Medicine. 150 (9): 604–612. doi:10.7326/0003-4819-150-9-200905050-00006. ISSN   0003-4819. PMC   2763564 . PMID   19414839.
  8. 1 2 Eneanya, Nwamaka Denise; Yang, Wei; Reese, Peter Philip (2019-07-09). "Reconsidering the Consequences of Using Race to Estimate Kidney Function". JAMA. 322 (2): 113–114. doi:10.1001/jama.2019.5774. ISSN   0098-7484. PMID   31169890. S2CID   174811377.
  9. Levey, Andrew S.; Tighiouart, Hocine; Titan, Silvia M.; Inker, Lesley A. (1 May 2020). "Estimation of Glomerular Filtration Rate With vs Without Including Patient Race". JAMA Internal Medicine. 180 (5): 793–795. doi:10.1001/jamainternmed.2020.0045. ISSN   2168-6106. PMC   7076535 . PMID   32176270.
  10. Hsu, Joy; Johansen, Kirsten L.; Hsu, Chi-yuan; Kaysen, George A.; Chertow, Glenn M. (2008-07-01). "Higher Serum Creatinine Concentrations in Black Patients with Chronic Kidney Disease: Beyond Nutritional Status and Body Composition". Clinical Journal of the American Society of Nephrology. 3 (4): 992–997. doi:10.2215/CJN.00090108. ISSN   1555-9041. PMC   2440282 . PMID   18417750.
  11. Rao, Panduranga S.; Schaubel, Douglas E.; Guidinger, Mary K.; Andreoni, Kenneth A.; Wolfe, Robert A.; Merion, Robert M.; Port, Friedrich K.; Sung, Randall S. (2009-07-27). "A Comprehensive Risk Quantification Score for Deceased Donor Kidneys: The Kidney Donor Risk Index". Transplantation. 88 (2): 231–236. doi: 10.1097/TP.0b013e3181ac620b . ISSN   0041-1337. PMID   19623019. S2CID   10388164.
  12. 1 2 Julian, B. A.; Gaston, R. S.; Brown, W. M.; Reeves‐Daniel, A. M.; Israni, A. K.; Schladt, D. P.; Pastan, S. O.; Mohan, S.; Freedman, B. I.; Divers, J. (2017). "Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index". American Journal of Transplantation. 17 (6): 1540–1548. doi:10.1111/ajt.14113. ISSN   1600-6143. PMC   5429996 . PMID   27862962.
  13. 1 2 Cannon, R. M.; Brock, G. N.; Marvin, M. R.; Slakey, D. P.; Buell, J. F. (2012). "The Contribution of Donor Quality to Differential Graft Survival in African American and Caucasian Renal Transplant Recipients". American Journal of Transplantation. 12 (7): 1776–1783. doi: 10.1111/j.1600-6143.2012.04091.x . ISSN   1600-6143. PMID   22594464. S2CID   26039487.
  14. Curtin, Sally C.; Kozak, Lola Jean (December 1998). "Decline in U.S. Cesarean Delivery Rate Appears to Stall". Birth. 25 (4): 259–262. doi:10.1046/j.1523-536x.1998.00259.x. ISSN   0730-7659. PMID   9892895.
  15. "VAGINAL BIRTH AFTER CESAREAN". mfmunetwork.bsc.gwu.edu. Retrieved 2020-10-17.
  16. Grobman, William A.; Lai, Yinglei; Landon, Mark B.; Spong, Catherine Y.; Leveno, Kenneth J.; Rouse, Dwight J.; Varner, Michael W.; Moawad, Atef H.; Caritis, Steve N.; Harper, Margaret; Wapner, Ronald J. (April 2007). "Development of a Nomogram for Prediction of Vaginal Birth After Cesarean Delivery". Obstetrics & Gynecology. 109 (4): 806–812. doi: 10.1097/01.aog.0000259312.36053.02 . ISSN   0029-7844. PMID   17400840. S2CID   25615796.
  17. 1 2 Vyas, Darshali A.; Eisenstein, Leo G.; Jones, David S. (2020-08-27). "Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms". New England Journal of Medicine. 383 (9): 874–882. doi: 10.1056/NEJMms2004740 . ISSN   0028-4793. PMID   32853499.
  18. Vyas, Darshali A.; Jones, David S.; Meadows, Audra R.; Diouf, Khady; Nour, Nawal M.; Schantz-Dunn, Julianna (May 2019). "Challenging the Use of Race in the Vaginal Birth after Cesarean Section Calculator". Women's Health Issues. 29 (3): 201–204. doi: 10.1016/j.whi.2019.04.007 . ISSN   1049-3867. PMID   31072754.
  19. Burney, P.; Jarvis, D.; Perez-Padilla, R. (January 2015). "The global burden of chronic respiratory disease in adults". The International Journal of Tuberculosis and Lung Disease. 19 (1): 10–20. doi:10.5588/ijtld.14.0446. ISSN   1815-7920. PMID   25519785.
  20. Kumar, Rajesh; Seibold, Max A.; Aldrich, Melinda C.; Williams, L. Keoki; Reiner, Alex P.; Colangelo, Laura; Galanter, Joshua; Gignoux, Christopher; Hu, Donglei; Sen, Saunak; Choudhry, Shweta (22 July 2010). "Genetic Ancestry in Lung-Function Predictions". New England Journal of Medicine. 363 (4): 321–330. doi:10.1056/NEJMoa0907897. ISSN   0028-4793. PMC   2922981 . PMID   20647190.
  21. Braun, Lundy; Wolfgang, Melanie; Dickersin, Kay (1 June 2013). "Defining race/ethnicity and explaining difference in research studies on lung function". European Respiratory Journal. 41 (6): 1362–1370. doi: 10.1183/09031936.00091612 . ISSN   0903-1936. PMID   22878881. S2CID   3092122.
  22. Skalski, Joseph H.; Gibson, Rachel A.; Narotzky, Sarah A.; Yadav, Hemang; Scanlon, Paul D. (2016). "5. Health Disparities and pulmonary function testing". In Gerald, Lynn B.; Berry, Cristine E. (eds.). Health Disparities in Respiratory Medicine. Switzerland: Humana Press. p. 101. doi:10.1007/978-3-319-23675-9. ISBN   978-3-319-23674-2. ISSN   2197-7372. LCCN   2015947791.
  23. 1 2 Linné, Carl von (1767). Caroli a Linné ... Systema naturae,: per regna tria naturae, secundum classes, ordines, genera, species, cum characteribus, differentiis, synonymis, locis (in Latin). Typis Ioannis Thomae.
  24. 1 2 Jackson, John P.; Weidman, Nadine M. (2004). Race, Racism, and Science: Social Impact and Interaction. ABC-CLIO. ISBN   978-1-85109-448-6.
  25. Harris, Marvin (2001-08-14). The Rise of Anthropological Theory: A History of Theories of Culture. AltaMira Press. ISBN   978-0-7591-1699-3.
  26. 1 2 Garrod, Joel Z. (January 2006). "A Brave Old World: An Analysis of Scientific Racism and BiDil®". McGill Journal of Medicine. 9 (1): 54–60. ISSN   1201-026X. PMC   2687899 . PMID   19529811.
  27. Claeys, Gregory (2000). "The "Survival of the Fittest" and the Origins of Social Darwinism". Journal of the History of Ideas. 61 (2): 223–240. doi:10.1353/jhi.2000.0014. ISSN   1086-3222. S2CID   146267804.
  28. Alexander Thomas and Samuell Sillen (1972). Racism and Psychiatry. New York: Carol Publishing Group.
  29. 1 2 3 Bachynski, Kathleen. "Perspective | American medicine was built on the backs of slaves. And it still affects how doctors treat patients today". Washington Post. ISSN   0190-8286 . Retrieved 2020-10-17.
  30. Vernon, Leonard F. (2019-08-01). "J. Marion Sims, MD: Why He and His Accomplishments Need to Continue to be Recognized a Commentary and Historical Review". Journal of the National Medical Association. 111 (4): 436–446. doi: 10.1016/j.jnma.2019.02.002 . ISSN   0027-9684. PMID   30851980.
  31. 1 2 Kapsalis, Terri (2002). "Mastering the Female Pelvis: Race and the Tools of Reproduction". In Wallace-Sanders, Kimberly (ed.). Skin Deep, Spirit Strong: The Black Female Body in American Culture (PDF). Ann Arbor, MI: University of Michigan Press. pp. 263–300. ISBN   978-0472067077.
  32. Meier, Allison C. (2018-08-24). "Grave Robbing, Black Cemeteries, and the American Medical School". JSTOR Daily. Retrieved 2020-10-17.
  33. "Tuskegee Study - Timeline - CDC - NCHHSTP". www.cdc.gov. 2020-07-16. Retrieved 2020-10-17.
  34. Tilley, Helen (2016-07-01). "Medicine, Empires, and Ethics in Colonial Africa". AMA Journal of Ethics. 18 (7): 743–753. doi: 10.1001/journalofethics.2016.18.7.mhst1-1607 . ISSN   2376-6980. PMID   27437825.
  35. Tilley, Helen (2011-04-15). Africa as a Living Laboratory: Empire, Development, and the Problem of Scientific Knowledge, 1870-1950. University of Chicago Press. ISBN   978-0-226-80348-7.
  36. Smith, Honor (1955-01-01). "Medicine in Africa as I have seen It". African Affairs. 54 (214): 28–36. doi:10.1093/oxfordjournals.afraf.a094264. ISSN   0001-9909.
  37. Kevles, Daniel J. (1985). In the Name of Eugenics: Genetics and the Uses of Human Heredity. Harvard University Press. ISBN   9780674445574.
  38. 1 2 3 Kolata, Gina (2020-07-21). "Many Medical Decision Tools Disadvantage Black Patients". The New York Times. ISSN   0362-4331 . Retrieved 2020-10-17.
  39. Obermeyer, Ziad; Powers, Brian; Vogeli, Christine; Mullainathan, Sendhil (25 October 2019). "Dissecting racial bias in an algorithm used to manage the health of populations". Science. 366 (6464): 447–453. Bibcode:2019Sci...366..447O. doi: 10.1126/science.aax2342 . ISSN   0036-8075. PMID   31649194. S2CID   204881868.
  40. "Leave Race Out of Kidney Function Estimates?". www.medpagetoday.com. 2 December 2020. Archived from the original on 20 April 2021. Retrieved 20 April 2021.
  41. "Push to remove racist bias from kidney testing gains new ground". STAT. 17 July 2020. Retrieved 2020-10-17.
  42. "UW Medicine to exclude race from calculation of eGFR (measure of kidney function) | Department of Medicine | University of Washington". medicine.uw.edu. Retrieved 2020-10-17.